Centessa Pharmaceuticals (CNTA) Treasury Shares (2021 - 2026)

Centessa Pharmaceuticals (CNTA) has 6 years of Treasury Shares data on file, last reported at $1.2 million in Q1 2026.

• Treasury Shares for Q1 2026 came in at $1.2 million, up 3222.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (up 3222.17% YoY), and the FY2025 annual result was $984059.0, down 34.83% from the prior year.
• Treasury Shares climbed to $1.2 million in Q1 2026 per CNTA's latest filing, from $984059.0 in the prior quarter.
• Over five years, Treasury Shares peaked at $2.2 million in Q2 2024 and troughed at $34746.0 in Q1 2025.
• A 5-year average of $815729.4 and a median of $686429.5 in 2022 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2025 and 2026: Treasury Shares sank 86.29% in 2025, then jumped 3222.17% in 2026.
• A 5-year view of Treasury Shares shows it stood at $1.8 million in 2022, then sank by 82.82% to $310052.0 in 2023, then soared by 387.04% to $1.5 million in 2024, then sank by 34.83% to $984059.0 in 2025, then increased by 17.3% to $1.2 million in 2026.
• Business Quant data shows CNTA's Treasury Shares at $1.2 million in Q1 2026, $984059.0 in Q4 2025, and $1.1 million in Q2 2025.